Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2385
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose ; volume:1 ; number:1 ; day:21 ; month:11 ; year:2001 ; pages:1-9 ; date:12.2001
BMC nuclear medicine ; 1, Heft 1 (21.11.2001), 1-9, 12.2001
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Savio, Eduardo
- Beteiligte Personen und Organisationen
-
Gaudiano, Javier
Robles, Ana M.
Balter, Henia
Paolino, Andrea
Lopez, Andrea
Hermida, Juan C.
De Marco, Eugenia
Martinez, Graciela
Osinaga, Eduardo
Knapp, Furn F.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2385-1-2
- URN
-
urn:nbn:de:1111-2017101413858
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Savio, Eduardo
- Gaudiano, Javier
- Robles, Ana M.
- Balter, Henia
- Paolino, Andrea
- Lopez, Andrea
- Hermida, Juan C.
- De Marco, Eugenia
- Martinez, Graciela
- Osinaga, Eduardo
- Knapp, Furn F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysis
New Theranostic Radionuclides for Metastatic Bone Disease : Biodistribution and Dosimetric Analysis
Technetium : chemistry and radiopharmaceutical applications
Radiopharmaceutical tracers for cardiac imaging
Good practices for 68Ga radiopharmaceutical production
From Osteocytes to Osseous Pathologies
Nasal angioma with osseous metaplasia
The Radiochemical and Radiopharmaceutical Applications of Radium
Production and separation of 43Sc for radiopharmaceutical purposes
Position statement on radiopharmaceutical production for clinical trials
Good practices for 89Zr radiopharmaceutical production and quality control
Institute of Bioinorganic and Radiopharmaceutical Chemistry; Annual Report 1992
Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysis
New Theranostic Radionuclides for Metastatic Bone Disease : Biodistribution and Dosimetric Analysis
Technetium : chemistry and radiopharmaceutical applications
Radiopharmaceutical tracers for cardiac imaging
Good practices for 68Ga radiopharmaceutical production
From Osteocytes to Osseous Pathologies
Nasal angioma with osseous metaplasia
The Radiochemical and Radiopharmaceutical Applications of Radium
Production and separation of 43Sc for radiopharmaceutical purposes
Position statement on radiopharmaceutical production for clinical trials
Good practices for 89Zr radiopharmaceutical production and quality control
Institute of Bioinorganic and Radiopharmaceutical Chemistry; Annual Report 1992
Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysis
New Theranostic Radionuclides for Metastatic Bone Disease : Biodistribution and Dosimetric Analysis
Technetium : chemistry and radiopharmaceutical applications
Radiopharmaceutical tracers for cardiac imaging
Good practices for 68Ga radiopharmaceutical production
From Osteocytes to Osseous Pathologies
Nasal angioma with osseous metaplasia
The Radiochemical and Radiopharmaceutical Applications of Radium
Production and separation of 43Sc for radiopharmaceutical purposes
Position statement on radiopharmaceutical production for clinical trials
Good practices for 89Zr radiopharmaceutical production and quality control